81 related articles for article (PubMed ID: 379641)
1. Graft-versus-host disease.
Thomas ED; Fefer A
N Engl J Med; 1979 Sep; 301(10):556. PubMed ID: 379641
[No Abstract] [Full Text] [Related]
2. [Graft-versus-leukemia effect (GVL effect): pathophysiological and clinical aspects].
Nakamura H
Nihon Rinsho; 1990 Sep; 48(9):1977-82. PubMed ID: 2232200
[No Abstract] [Full Text] [Related]
3. [Hematopoietic stem-cell transplantation in aplastic anemia].
Hernández-Rivera EG
Rev Invest Clin; 2005; 57(2):298-304. PubMed ID: 16524071
[TBL] [Abstract][Full Text] [Related]
4. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts.
Weiden PL; Flournoy N; Thomas ED; Prentice R; Fefer A; Buckner CD; Storb R
N Engl J Med; 1979 May; 300(19):1068-73. PubMed ID: 34792
[TBL] [Abstract][Full Text] [Related]
5. Marrow transplantation for treatment of aplastic anaemia.
Storb R; Thomas ED
Clin Haematol; 1978 Oct; 7(3):597-609. PubMed ID: 31255
[No Abstract] [Full Text] [Related]
6. Rat cytomegalovirus can be transferred by bone marrow cells but does not affect the course of acute graft-versus-host disease.
Bos GM; Majoor GD; Bruggeman CA; Grauls G; van de Gaar MJ; van Breda Vriesman PJ
Transplant Proc; 1989 Feb; 21(1 Pt 3):3050-2. PubMed ID: 2539684
[No Abstract] [Full Text] [Related]
7. Does thymic epithelial cell insufficiency predispose to chronic graft-versus-host disease after bone marrow transplantation?
Boland J; Atkinson K; Bodinnar T; Biggs J
Transplant Proc; 1985 Apr; 17(2):1709-10. PubMed ID: 3885511
[No Abstract] [Full Text] [Related]
8. Induction of autologous graft-versus-host disease.
Vogelsang GB; Jones RJ; Hess AD; Geller R; Schucter L; Santos GW
Transplant Proc; 1989 Feb; 21(1 Pt 3):2997-8. PubMed ID: 2650411
[No Abstract] [Full Text] [Related]
9. Syngeneic graft-versus-host disease: a report of two cases and literature review.
Latif T; Pohlman B; Kalaycio M; Sobecks R; Hsi ED; Andresen S; Bolwell BJ
Bone Marrow Transplant; 2003 Sep; 32(5):535-9. PubMed ID: 12942102
[TBL] [Abstract][Full Text] [Related]
10. Acute graft-versus-host disease in recipients of bone-marrow transplants from identical twin donors.
Barnes DW; Loutit JF
Lancet; 1979 Oct; 2(8148):905-6. PubMed ID: 91000
[No Abstract] [Full Text] [Related]
11. Syngeneic graft-vs-host disease.
Ferrara JL
Arch Dermatol; 1987 Jun; 123(6):741-2. PubMed ID: 3555352
[No Abstract] [Full Text] [Related]
12. Graft-versus-leukemia following bone marrow transplantation.
Butturini A; Bortin MM; Gale RP
Bone Marrow Transplant; 1987 Oct; 2(3):233-42. PubMed ID: 3332173
[TBL] [Abstract][Full Text] [Related]
13. [Bone marrow transplant in chronic myeloid leukemia].
Fernańdez-Rañada JM; Vázquez L; Fernańdez-Garese D; Gómez Reino F; Solano C; González N; Lozano M; Fernández-Villalta MJ
Sangre (Barc); 1984; 29(4-B):598-606. PubMed ID: 6393384
[No Abstract] [Full Text] [Related]
14. Regulation of syngeneic graft-versus-host disease by autosuppressor mechanisms.
Hess AD; Fischer AC; Beschorner WE
Transplant Proc; 1989 Feb; 21(1 Pt 3):3013-5. PubMed ID: 2523169
[No Abstract] [Full Text] [Related]
15. [Bone marrow transplantation. II. A patient with leukemic lymphosarcomatosis received a marrow infusion from a normal identical twin after whole body irradiation (author's transl)].
Sato M; Moriyama Y; Ohno Y; Kurokawa I; Saito H; Kozima K
Rinsho Ketsueki; 1978 Mar; 19(3):264-71. PubMed ID: 359855
[No Abstract] [Full Text] [Related]
16. Excellent long-term survival after allogeneic marrow transplantation in patients with severe aplastic anemia.
Reiter E; Keil F; Brugger S; Kalhs P; Rabitsch W; Hinterberger W; Fischer G; Rosenmayr A; Haas O; Volc B; Lechner K; Greinix HT
Bone Marrow Transplant; 1997 Jun; 19(12):1191-6. PubMed ID: 9208112
[TBL] [Abstract][Full Text] [Related]
17. Graft-versus-leukemia in chronic lymphocytic leukemia.
Ben-Bassat I; Raanani P; Gale RP
Bone Marrow Transplant; 2007 Apr; 39(8):441-6. PubMed ID: 17322931
[TBL] [Abstract][Full Text] [Related]
18. [Bone marrow transplantation in leukemia: possibilities and problems].
Speck B
Schweiz Med Wochenschr; 1975 Oct; 105(40):1286-9. PubMed ID: 766171
[TBL] [Abstract][Full Text] [Related]
19. Prolactin: a possible mediator of graft-versus-host disease following allogeneic bone marrow transplantation in humans.
Hinterberger-Fischer M; Kier P; Spona J; Sebesta C; Tiefengraber E; Habertheuer KH; Ruckser R; Schmid A; Kalhs P; Lechner K
Bone Marrow Transplant; 1994 Sep; 14(3):403-6. PubMed ID: 7994262
[TBL] [Abstract][Full Text] [Related]
20. Helper T-lymphocyte precursor frequency predicts the occurrence of graft-versus-host disease and disease relapse after allogeneic bone marrow transplantation from HLA-identical siblings.
Leung AY; Kwok J; Lie AK; Chen P; Chen FE; Liang R
Haematologica; 2001 Jun; 86(6):652-6. PubMed ID: 11418376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
